Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: Lessons from the Nationwide Israeli-ICD Registry

Europace

Volumn 16, Issue 8, 2014, Pages 1175-1180

  Amit, Guy ^a,b   Suleiman, Mahmoud ^c   Konstantino, Yuval ^a   Luria, David ^a,d   Kazatsker, Mark ^e   Chetboun, Israel ^f   Haim, Moti ^f   Gavrielov Yusim, Natalie ^g   Goldenberg, Ilan ^g   Glikson, Michael ^a,d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MCMASTER UNIVERSITY   (Canada)

^c RAMBAM MEDICAL CENTER   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e HILLEL YAFFE MEDICAL CENTER   (Israel)

^f MEIR MEDICAL CENTER   (Israel)

^g TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cardiac resynchronization therapy; Implantable cardioverter defibrillators; Outcomes; Registry; Women

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DEVICE THERAPY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IMPLANT REGISTRY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; ISCHEMIC CARDIOMYOPATHY; ISRAEL; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QRS COMPLEX; SECONDARY PREVENTION; SEX DIFFERENCE; SMOKING; TREATMENT INDICATION; ADVERSE EFFECTS; AGED; ARRHYTHMIAS, CARDIAC; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVERSION; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; DEATH, SUDDEN, CARDIAC; DEVICES; HEALTH CARE DISPARITY; HEALTH DISPARITY; HOSPITALIZATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REGISTER; RETREATMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

AGED; ARRHYTHMIAS, CARDIAC; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HEART FAILURE; HOSPITALIZATION; HUMANS; ISRAEL; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RETREATMENT; RISK FACTORS; SECONDARY PREVENTION; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84905669650     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu015     Document Type: Article

References (16)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
2. Moss AJ, ZarebaW, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-37.
4. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators.Acomparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337: 1576-83.
5. Connolly SJ, Gent M, Roberts RS,DorianP,RoyD, SheldonRSet al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.
6. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythmabnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/ AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51: e1-62.
7. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/ AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of theAmerican College of Cardiology/ American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837.
8. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 2007;298:1517-24.
9. MacFadden DR, Tu JV, Chong A, Austin PC, Lee DS. Evaluating sex differences in population-based utilization of implantable cardioverter- defibrillators: role of cardiac conditions and noncardiac comorbidities. Heart Rhythm 2009;6:1289-96.
10. Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S et al. Effectiveness of implantable cardioverter defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med 2009;169:1500-6.
11. MacFadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P et al. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med 2012;156:195-203.
12. Attin M, Ideker RE, Pogwizd SM. Mechanistic insights into ventricular arrhythmias from mapping studies in humans. Heart Rhythm 2008;5(suppl):S53-8.
13. Arshad A, Moss AJ, Foster E, Padeletti L, Barsheshet A, Goldenberg I et al. MADIT-CRT Executive Committee. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol 2011;57:813-20.
14. Barsheshet A, Brenyo A, Goldenberg I, Moss AJ. Sex-related differences in patients' responses to heart failure therapy. Nat Rev Cardiol 2012;9:234-42.
15. Cheng A, Gold MR, Waggoner AD, Meyer TE, Seth M, Rapkin J et al. Potential mechanisms underlying the effect of gender on response to cardiac resynchronization therapy: insights from the SMART-AV multicenter trial. Heart Rhythm 2012;9: 736-41.
16. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP et al. National Cardiovascular Data Registry. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 2009;119:1078-84.